Conservest Capital Advisors’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,555
Closed -$3K 101
2022
Q1
$3K Buy
+10,555
New +$3.72K ﹤0.01% 88

Other funds holding ATIP.WS

Conservest Capital Advisors's ATIP.WS Position: Q2 2022 in Review

Conservest Capital Advisors sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q2 2022, closing a stake of 10,555 shares — an estimated $3K sold.

Conservest Capital Advisors first reported a position in ATIP.WS in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 18 funds tracked by Wall St. Rank hold ATIP.WS as of Q2 2022.

  • Conservest Capital Advisors reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
  • Conservest Capital Advisors sold 10,555 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q2 2022, an estimated $3K.
  • Conservest Capital Advisors first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q1 2022 and held it in 1 quarter.
  • Conservest Capital Advisors's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $3K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q2 2022.

Based on Conservest Capital Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.